Mission Bio

FromMission Bio Webinars ([email protected])
Sent withSalesforce Marketing Cloud
Subject (80)BLAST Trial: Single-cell CXCR4 expression predicts Motixafortide response in AML
Preheader (149)Hi New clinical data from the investigator-initiated Phase II BLAST trial highlights a potential biomarker for predicting treatment response in acute
Typography
Arial
Colors
Text Analysis
Body Words170
Subject Words10
Body Emojis1
Subject Emojis
Media Analysis
Text Links2
Image Links2
Total Links4
Images5
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px1273 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeEvening

BLAST Trial: Single-cell CXCR4 expression predicts Motixafortide response in AML

Hi New clinical data from the investigator-initiated Phase II BLAST trial highlights a potential biomarker for predicting treatment response in acute
BLAST Trial: Single-cell CXCR4 expression predicts Motixafortide response in AML